KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

August 26, 2022

Study Completion Date

August 26, 2022

Conditions
Small-cell Lung CancerSmall Cell Lung CarcinomaSmall Cell Lung Cancer Extensive StageSmall Cell Lung Cancer Recurrent
Interventions
DRUG

KRT-232

Administered by mouth

Trial Locations (33)

3010

Hospital General Universitario de Alicante, Alicante

5042

Flinders Medical Centre, Bedford Park

6000

Bacs Kiskun Megyei Korhaz, Kecskemét

13125

Evangelische Lungenklinik Berlin, Berlin

13520

CHA Bundang Medical Center, CHA University, Seongnam-si

13915

Hopital Nord AP-HM, Marseille

28007

Hospital Universitario 12 de Octubre, Alicante

28027

Clinica Universidad Navarra - Madrid, Madrid

28046

Hospital Universitario La Paz, Madrid

28644

Chungbuk National University Hospital, Cheongju-si

29011

Hospital Regional Universitario de Malaga - Hospital Civil, Málaga

30060

Northwest Georgia Oncology Centers, Marietta

31008

Clinica Universidad Navarra, Pamplona

33000

EDOG - Institut Bergonie - PPDS, Bordeaux

33401

Florida Cancer Specialists, West Palm Beach

33705

Florida Cancer Specialists - 560 Jackson St, Suite 220, St. Petersburg

33901

Florida Cancer Specialists - 3840 Broadway, Fort Myers

34376

Lungenfachklinik Immenhausen, Immenhausen

37205

SCRI Tennessee Oncology Nashville, Nashville

37404

SCRI Tennessee Oncology Chattanooga, Chattanooga

38043

CHU de Grenoble, Grenoble

41071

Hospital Universitario Virgen Macarena, Seville

43213

Mark H Zangmeister Center - 3100 Plaza Properties Boulevard, Columbus

44106

University Hospitals Cleveland Medical Center, Cleveland

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

49933

Edog - Ico - Ppds, Angers

68000

Centre Hospitalier de Mulhouse - Hopital Emile Muller, Mulhouse

69310

Hôpital de La Croix Rousse, Pierre-Bénite

69495

Hospices Civils de Lyon, Lyon

69677

Hôpital Louis Pradel, Bron

70809

Hematology Oncology Clinic, Baton Rouge

73730

Klinik für Kardiologie, Angiologie und Pneumologie, Esslingen am Neckar

0825

Hospital Universitario Vall d'Hebrón - PPDS, Barcelona

Sponsors
All Listed Sponsors
lead

Kartos Therapeutics, Inc.

INDUSTRY

NCT05027867 - KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter